| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T0 |
50-74 |
DISEASE |
denotes |
focal cortical dysplasia |
| T1 |
79-98 |
DISEASE |
denotes |
refractory epilepsy |
| T2 |
100-124 |
DISEASE |
denotes |
Focal cortical dysplasia |
| T3 |
126-129 |
DISEASE |
denotes |
FCD |
| T4 |
134-140 |
REG |
denotes |
caused |
| T5 |
153-164 |
VAR |
denotes |
alterations |
| T6 |
192-205 |
REG |
denotes |
abnormalities |
| T7 |
213-234 |
CPA |
denotes |
cortical architecture |
| T8 |
239-261 |
CPA |
denotes |
cytological variations |
| T9 |
282-290 |
REG |
denotes |
etiology |
| T10 |
294-297 |
DISEASE |
denotes |
FCD |
| T11 |
319-329 |
REG |
denotes |
generation |
| T12 |
365-370 |
CPA |
denotes |
iPSCs |
| T13 |
404-425 |
DISEASE |
denotes |
neurological diseases |
| T14 |
448-479 |
CPA |
denotes |
tissue‑specific differentiation |
| T15 |
481-487 |
REG |
denotes |
serves |
| T16 |
549-560 |
CPA |
denotes |
development |
| T17 |
576-587 |
CPA |
denotes |
progression |
| T18 |
600-610 |
REG |
denotes |
associated |
| T19 |
666-679 |
REG |
denotes |
demonstrating |
| T20 |
689-699 |
NEGREG |
denotes |
refractory |
| T21 |
719-732 |
REG |
denotes |
characterized |
| T22 |
736-748 |
DISEASE |
denotes |
FCD Type IIb |
| T23 |
933-938 |
CPA |
denotes |
iPSCs |
| T24 |
944-953 |
REG |
denotes |
generated |
| T25 |
1016-1038 |
GENE |
denotes |
POU class 5 homeobox 1 |
| T26 |
1040-1044 |
GENE |
denotes |
OCT4 |
| T27 |
1047-1077 |
GENE |
denotes |
sex determining region Y‑box 2 |
| T28 |
1079-1083 |
GENE |
denotes |
SOX2 |
| T29 |
1086-1107 |
GENE |
denotes |
Kruppel‑like factor 4 |
| T30 |
1112-1117 |
GENE |
denotes |
c‑MYC |
| T31 |
1134-1147 |
REG |
denotes |
characterized |
| T32 |
1225-1230 |
GENE |
denotes |
NANOG |
| T33 |
1232-1236 |
GENE |
denotes |
SOX2 |
| T34 |
1238-1242 |
GENE |
denotes |
OCT4 |
| T35 |
1244-1251 |
GENE |
denotes |
TRA1‑60 |
| T36 |
1256-1263 |
GENE |
denotes |
TRA1‑81 |
| T37 |
1319-1335 |
GENE |
denotes |
protein kinase B |
| T38 |
1337-1340 |
GENE |
denotes |
AKT |
| T39 |
1343-1361 |
GENE |
denotes |
phosphorylated‑AKT |
| T40 |
1363-1394 |
GENE |
denotes |
mechanistic target of rapamycin |
| T41 |
1396-1400 |
GENE |
denotes |
mTOR |
| T42 |
1406-1425 |
GENE |
denotes |
phosphorylated‑mTOR |
| T43 |
1443-1459 |
PATHWAY |
denotes |
AKT/mTOR pathway |
| T44 |
1460-1468 |
REG |
denotes |
revealed |
| T45 |
1497-1507 |
REG |
denotes |
difference |
| T46 |
1626-1648 |
CPA |
denotes |
morphological features |
| T47 |
1652-1667 |
CPA |
denotes |
embryonic cells |
| T48 |
1673-1681 |
REG |
denotes |
detected |
| T49 |
1707-1720 |
REG |
denotes |
characterized |
| T50 |
1754-1762 |
POSREG |
denotes |
positive |
| T51 |
1795-1810 |
CPA |
denotes |
embryonic cells |
| T52 |
1811-1820 |
REG |
denotes |
confirmed |
| T53 |
1836-1846 |
REG |
denotes |
generation |
| T54 |
1850-1855 |
CPA |
denotes |
iPSCs |
| T55 |
1925-1933 |
REG |
denotes |
presents |
| T56 |
2006-2033 |
CPA |
denotes |
embryonic brain development |
| T57 |
2034-2044 |
REG |
denotes |
associated |
| T58 |
2050-2053 |
DISEASE |
denotes |
FCD |
| R0 |
T2 |
T4 |
ThemeOf |
Focal cortical dysplasia,caused |
| R4 |
T10 |
T9 |
ThemeOf |
FCD,etiology |
| R5 |
T13 |
T15 |
ThemeOf |
neurological diseases,serves |
| R6 |
T16 |
T15 |
ThemeOf |
development,serves |
| R7 |
T16 |
T18 |
ThemeOf |
development,associated |
| R8 |
T17 |
T15 |
ThemeOf |
progression,serves |
| R33 |
T51 |
T50 |
ThemeOf |
embryonic cells,positive |
| R34 |
T51 |
T52 |
ThemeOf |
embryonic cells,confirmed |
| R35 |
T54 |
T52 |
ThemeOf |
iPSCs,confirmed |
| R36 |
T54 |
T53 |
ThemeOf |
iPSCs,generation |
| R37 |
T56 |
T57 |
ThemeOf |
embryonic brain development,associated |
| R38 |
T58 |
T56 |
ThemeOf |
FCD,embryonic brain development |
| R39 |
T58 |
T57 |
ThemeOf |
FCD,associated |
| R1 |
T2 |
T5 |
ThemeOf |
Focal cortical dysplasia,alterations |
| R2 |
T3 |
T4 |
ThemeOf |
FCD,caused |
| R3 |
T7 |
T6 |
ThemeOf |
cortical architecture,abnormalities |
| R9 |
T17 |
T18 |
ThemeOf |
progression,associated |
| R10 |
T20 |
T19 |
ThemeOf |
refractory,demonstrating |
| R11 |
T22 |
T19 |
ThemeOf |
FCD Type IIb,demonstrating |
| R12 |
T22 |
T21 |
ThemeOf |
FCD Type IIb,characterized |
| R13 |
T23 |
T24 |
ThemeOf |
iPSCs,generated |
| R14 |
T25 |
T31 |
ThemeOf |
POU class 5 homeobox 1,characterized |
| R15 |
T26 |
T31 |
ThemeOf |
OCT4,characterized |
| R16 |
T27 |
T31 |
ThemeOf |
sex determining region Y‑box 2,characterized |
| R17 |
T28 |
T31 |
ThemeOf |
SOX2,characterized |
| R18 |
T29 |
T31 |
ThemeOf |
Kruppel‑like factor 4,characterized |
| R19 |
T30 |
T31 |
ThemeOf |
c‑MYC,characterized |
| R20 |
T32 |
T31 |
ThemeOf |
NANOG,characterized |
| R21 |
T33 |
T31 |
ThemeOf |
SOX2,characterized |
| R22 |
T34 |
T31 |
ThemeOf |
OCT4,characterized |
| R23 |
T35 |
T31 |
ThemeOf |
TRA1‑60,characterized |
| R24 |
T36 |
T31 |
ThemeOf |
TRA1‑81,characterized |
| R25 |
T43 |
T44 |
ThemeOf |
AKT/mTOR pathway,revealed |
| R26 |
T43 |
T45 |
ThemeOf |
AKT/mTOR pathway,difference |
| R27 |
T45 |
T44 |
ThemeOf |
difference,revealed |
| R28 |
T47 |
T46 |
ThemeOf |
embryonic cells,morphological features |
| R29 |
T46 |
T48 |
ThemeOf |
morphological features,detected |
| R30 |
T46 |
T49 |
ThemeOf |
morphological features,characterized |
| R31 |
T47 |
T48 |
ThemeOf |
embryonic cells,detected |
| R32 |
T47 |
T49 |
ThemeOf |
embryonic cells,characterized |
